Association of NOD2 Leucine-rich Repeat Variants with Susceptibility to Crohn's Disease
Authors
Affiliations
Crohn's disease and ulcerative colitis, the two main types of chronic inflammatory bowel disease, are multifactorial conditions of unknown aetiology. A susceptibility locus for Crohn's disease has been mapped to chromosome 16. Here we have used a positional-cloning strategy, based on linkage analysis followed by linkage disequilibrium mapping, to identify three independent associations for Crohn's disease: a frameshift variant and two missense variants of NOD2, encoding a member of the Apaf-1/Ced-4 superfamily of apoptosis regulators that is expressed in monocytes. These NOD2 variants alter the structure of either the leucine-rich repeat domain of the protein or the adjacent region. NOD2 activates nuclear factor NF-kB; this activating function is regulated by the carboxy-terminal leucine-rich repeat domain, which has an inhibitory role and also acts as an intracellular receptor for components of microbial pathogens. These observations suggest that the NOD2 gene product confers susceptibility to Crohn's disease by altering the recognition of these components and/or by over-activating NF-kB in monocytes, thus documenting a molecular model for the pathogenic mechanism of Crohn's disease that can now be further investigated.
Li Y, Ascui G, Dicker M, Riffelmacher T, Chandra V, Schmiedel B Nat Commun. 2025; 16(1):2577.
PMID: 40089498 DOI: 10.1038/s41467-025-57744-3.
Aljohani H, Anbarserry D, Mosli M, Ujaimi A, Bakhshwin D, Elango R Biomedicines. 2025; 13(2).
PMID: 40002872 PMC: 11852680. DOI: 10.3390/biomedicines13020459.
Risk factors for inflammatory bowel disease: an umbrella review.
Wu T, Cheng H, Zhuang J, Liu X, Ouyang Z, Qian R Front Cell Infect Microbiol. 2025; 14:1410506.
PMID: 39926114 PMC: 11802543. DOI: 10.3389/fcimb.2024.1410506.
Yuan Z, Ye J, Liu B, Zhang L Adv Biotechnol (Singap). 2025; 2(2):14.
PMID: 39883213 PMC: 11740883. DOI: 10.1007/s44307-024-00021-z.
[Update on the pathophysiology, prediction and prevention of inflammatory bowel diseases].
Fischer S, Neurath M Inn Med (Heidelb). 2025; 66(2):137-145.
PMID: 39833377 DOI: 10.1007/s00108-024-01838-5.